BACKGROUND: One-third of individuals with acute low back pain (LBP) experience recurrent symptoms within 12 months but the underlying mechanisms are unclear. One explanation is that individuals experiencing recurrent LBP develop altered central pain processing that predisposes to symptom recurrence. We compared central pain processing between individuals experiencing their first episode of acute LBP, recurrent acute LBP, and pain-free controls. METHODS: A cross-sectional study was conducted to evaluate central pain processing in 11 individuals experiencing their first episode of acute LBP, 11 individuals with recurrent acute LBP, and 11 pain-free controls. Outcome measures included pain and disability, pressure and heat pain thresholds (PPT...
Low back pain has a life time prevalence of 70% to 85%. Approximately 10% to 20% of all patients exp...
Generalized hyperalgesia and impaired pain modulation are reported in chronic low back pain (LBP). F...
Low back pain has a life time prevalence of 70% to 85%. Approximately 10% to 20% of all patients exp...
Central sensitisation is considered to have a pathophysiological role in chronic low back pain (LBP)...
OBJECTIVE: The purpose of this narrative review is to analyze the available literature concerning ce...
Background: Early evidence suggests human assumed central sensitization (HACS) is present in some pe...
Abstract. Introduction:. Chronic low back pain (LBP) is commonly associated with generalised pain hy...
OBJECTIVES Disturbed endogenous pain modulation is likely one of the mechanisms underlying centra...
This prospective study of acute and sub-acute low back pain (LBP) patients was conducted to assess w...
Patient characteristics associated with the course and severity of low back pain (LBP) and disabilit...
OBJECTIVES:: Widespread central hypersensitivity and altered conditioned pain modulation (CPM) have ...
Background: The impairment in musculoskeletal structures in patients with low back pain (LBP) is oft...
The aim of this case-control study was to examine differences in neural correlates of pain facilitat...
In low back pain (LBP), primary care and secondary prevention of recurrent and persistent LBP are no...
Background: Dysfunctional motor control of the back muscles is observed in people suffering from non...
Low back pain has a life time prevalence of 70% to 85%. Approximately 10% to 20% of all patients exp...
Generalized hyperalgesia and impaired pain modulation are reported in chronic low back pain (LBP). F...
Low back pain has a life time prevalence of 70% to 85%. Approximately 10% to 20% of all patients exp...
Central sensitisation is considered to have a pathophysiological role in chronic low back pain (LBP)...
OBJECTIVE: The purpose of this narrative review is to analyze the available literature concerning ce...
Background: Early evidence suggests human assumed central sensitization (HACS) is present in some pe...
Abstract. Introduction:. Chronic low back pain (LBP) is commonly associated with generalised pain hy...
OBJECTIVES Disturbed endogenous pain modulation is likely one of the mechanisms underlying centra...
This prospective study of acute and sub-acute low back pain (LBP) patients was conducted to assess w...
Patient characteristics associated with the course and severity of low back pain (LBP) and disabilit...
OBJECTIVES:: Widespread central hypersensitivity and altered conditioned pain modulation (CPM) have ...
Background: The impairment in musculoskeletal structures in patients with low back pain (LBP) is oft...
The aim of this case-control study was to examine differences in neural correlates of pain facilitat...
In low back pain (LBP), primary care and secondary prevention of recurrent and persistent LBP are no...
Background: Dysfunctional motor control of the back muscles is observed in people suffering from non...
Low back pain has a life time prevalence of 70% to 85%. Approximately 10% to 20% of all patients exp...
Generalized hyperalgesia and impaired pain modulation are reported in chronic low back pain (LBP). F...
Low back pain has a life time prevalence of 70% to 85%. Approximately 10% to 20% of all patients exp...